Navega Therapeutics, Inc.
San Diego, CA
- UEI
- EDSAQ1DMYLK7
- CAGE
- 84UY5
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 3210 Merryfield Row, San Diego, CA 92121, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Navega Therapeutics, Inc.
Navega Therapeutics, Inc. is a San Diego-based biotechnology company focused on developing innovative epigenetic gene therapies for chronic pain management. Registered in SAM.gov since June 20, 2018, the company is classified as a minority-owned, woman-owned, and Hispanic American-owned small business that operates as a for-profit organization. Their core research concentrates on developing non-addictive therapeutic approaches targeting voltage-gated sodium channels, particularly the NAV1.7 channel, to provide alternative pain management solutions that could reduce reliance on traditional opioid-based treatments.
The company has secured multiple federal grant awards from prestigious institutes, including the National Institute of Neurological Disorders and Stroke (NINDS), the National Cancer Institute, and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). These project grants, ranging from $297,327 to $400,000, support Navega's research into gene therapy treatments for various pain conditions such as chemotherapy-induced peripheral neuropathy, rheumatoid arthritis, and erythromelalgia. Their innovative approach involves developing epigenetic modulators that can transiently repress sodium channel expression, offering potential long-lasting pain relief without permanent genomic modifications. The research aims to create non-addictive, targeted therapies that can address chronic pain by specifically targeting sodium channels like NAV1.7 and NAV1.8, with the ultimate goal of preparing investigational new drug (IND) applications and advancing these therapies toward clinical development.
Quick answers
What is Navega Therapeutics, Inc.'s UEI?
Navega Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is EDSAQ1DMYLK7.
What is Navega Therapeutics, Inc.'s CAGE code?
Navega Therapeutics, Inc.'s CAGE code is 84UY5.
What is Navega Therapeutics, Inc.'s primary NAICS code?
Navega Therapeutics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Navega Therapeutics, Inc. located?
Navega Therapeutics, Inc.'s physical address in SAM.gov is 3210 Merryfield Row, San Diego, CA 92121, USA.
Is Navega Therapeutics, Inc. registered in SAM.gov?
Yes. Navega Therapeutics, Inc.'s SAM.gov registration is active through April 16, 2027.
What is Navega Therapeutics, Inc.'s most recent federal award?
Navega Therapeutics, Inc.'s most recent federal grant award is Reformulating NT-Z001 and its delivery route to treat rheumatoid arthritis - project absract a significant proportion of… (R43AR086088), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases, on September 18, 2025.
On GovTribe
See Navega Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors